NCT05880836View on ClinicalTrials.gov

In Line Aerosol Nebulization With High Flow

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Hypoxemic Respiratory FailureAirway Obstruction
Interventions
DEVICE

nebulizer via in-line drug delivery maintaining high-flow nasal cannula oxygen

nebulized delivery of bronchodilator via in-line drug delivery maintaining high-flow nasal cannula oxygen

DEVICE

standard jet nebulization (SJN) with face mask

standard jet nebulization delivery of bronchodilator

Trial Locations (2)

90095

Ronald Reagan Medical Center at UCLA, Los Angeles

90404

Santa Monica UCLA, Santa Monica

Sponsors

Collaborators (1)

Aerogen
All Listed Sponsors
collaborator

Aerogen

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT05880836 - In Line Aerosol Nebulization With High Flow | Biotech Hunter | Biotech Hunter